静脉注射用免疫球蛋白在儿童血液/肿瘤性疾病中应用的儿科专家共识

2021-04-10 中国当代儿科杂志.2021,23(4):319-327.

静脉注射用免疫球蛋白（IVIG）在恶性血液肿瘤化疗、靶向治疗及造血干细胞移植中的应用越来越普遍，但国内外尚无儿童血液/ 肿瘤性疾病中IVIG 应用的临床指南或共识。该共识基于儿童血液/ 肿瘤性疾病中I

中文标题：

发布机构：

发布日期：

2021-04-10

简要介绍：

静脉注射用免疫球蛋白（IVIG）在恶性血液肿瘤化疗、靶向治疗及造血干细胞移植中的应用越来越普遍，但国内外尚无儿童血液/ 肿瘤性疾病中IVIG 应用的临床指南或共识。该共识基于儿童血液/ 肿瘤性疾病中IVIG 应用的国内外研究进展而制定，对IVIG 在儿童血液/ 肿瘤性疾病中的临床应用策略及其不良反应的防治提出具体建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=9e43e1c00208e596, title=静脉注射用免疫球蛋白在儿童血液/肿瘤性疾病中应用的儿科专家共识, enTitle=, guiderFrom=中国当代儿科杂志.2021,23(4):319-327., authorId=0, author=, summary=静脉注射用免疫球蛋白（IVIG）在恶性血液肿瘤化疗、靶向治疗及造血干细胞移植中的应用越来越普遍，但国内外尚无儿童血液/ 肿瘤性疾病中IVIG 应用的临床指南或共识。该共识基于儿童血液/ 肿瘤性疾病中I, cover=https://img.medsci.cn/2021424/1619278690541_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sat Apr 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>静脉注射用免疫球蛋白（IVIG）在恶性血液肿瘤化疗、靶向治疗及造血干细胞移植中的应用越来越普遍，但国内外尚无儿童血液/ 肿瘤性疾病中IVIG 应用的临床指南或共识。该共识基于儿童血液/ 肿瘤性疾病中IVIG 应用的国内外研究进展而制定，对IVIG 在儿童血液/ 肿瘤性疾病中的临床应用策略及其不良反应的防治提出具体建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=4108, tagName=免疫球蛋白)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=4108, guiderKeyword=免疫球蛋白, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4011, appHits=93, showAppHits=0, pcHits=296, showPcHits=3917, likes=3, shares=8, comments=8, approvalStatus=1, publishedTime=Sat Apr 24 23:41:20 CST 2021, publishedTimeString=2021-04-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Apr 24 23:38:18 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:52:59 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=静脉注射用免疫球蛋白在儿童血液.pdf)])

静脉注射用免疫球蛋白在儿童血液.pdf

下载请点击：

评论区 (7)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1235361, encodeId=24841235361eb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc55266753, createdName=不知怎么, createdTime=Thu Jul 28 20:57:30 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074586, encodeId=844d10e4586e9, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 19:52:05 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062323, encodeId=d53510623233d, content=学习一下。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3c5555302, createdName=ms2000001082758263, createdTime=Wed Oct 20 18:32:57 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013244, encodeId=5782101324489, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56812497153, createdName=张家小胖子爱学习, createdTime=Tue Aug 31 17:21:18 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971208, encodeId=4ac19e1208f2, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sat Jun 05 23:10:59 CST 2021, time=2021-06-05, status=1, ipAttribution=)]
2022-07-28 不知怎么

学习学习

60 0
[GetPortalCommentsPageByObjectIdResponse(id=1235361, encodeId=24841235361eb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc55266753, createdName=不知怎么, createdTime=Thu Jul 28 20:57:30 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074586, encodeId=844d10e4586e9, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 19:52:05 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062323, encodeId=d53510623233d, content=学习一下。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3c5555302, createdName=ms2000001082758263, createdTime=Wed Oct 20 18:32:57 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013244, encodeId=5782101324489, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56812497153, createdName=张家小胖子爱学习, createdTime=Tue Aug 31 17:21:18 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971208, encodeId=4ac19e1208f2, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sat Jun 05 23:10:59 CST 2021, time=2021-06-05, status=1, ipAttribution=)]
2021-11-27 ms8000001755238620

学习下

87 0
[GetPortalCommentsPageByObjectIdResponse(id=1235361, encodeId=24841235361eb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc55266753, createdName=不知怎么, createdTime=Thu Jul 28 20:57:30 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074586, encodeId=844d10e4586e9, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 19:52:05 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062323, encodeId=d53510623233d, content=学习一下。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3c5555302, createdName=ms2000001082758263, createdTime=Wed Oct 20 18:32:57 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013244, encodeId=5782101324489, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56812497153, createdName=张家小胖子爱学习, createdTime=Tue Aug 31 17:21:18 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971208, encodeId=4ac19e1208f2, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sat Jun 05 23:10:59 CST 2021, time=2021-06-05, status=1, ipAttribution=)]
2021-10-20 ms2000001082758263

学习一下。

86 0
[GetPortalCommentsPageByObjectIdResponse(id=1235361, encodeId=24841235361eb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc55266753, createdName=不知怎么, createdTime=Thu Jul 28 20:57:30 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074586, encodeId=844d10e4586e9, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 19:52:05 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062323, encodeId=d53510623233d, content=学习一下。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3c5555302, createdName=ms2000001082758263, createdTime=Wed Oct 20 18:32:57 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013244, encodeId=5782101324489, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56812497153, createdName=张家小胖子爱学习, createdTime=Tue Aug 31 17:21:18 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971208, encodeId=4ac19e1208f2, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sat Jun 05 23:10:59 CST 2021, time=2021-06-05, status=1, ipAttribution=)]
2021-08-31 张家小胖子爱学习

谢谢

0 0
[GetPortalCommentsPageByObjectIdResponse(id=1235361, encodeId=24841235361eb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fc55266753, createdName=不知怎么, createdTime=Thu Jul 28 20:57:30 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074586, encodeId=844d10e4586e9, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 19:52:05 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062323, encodeId=d53510623233d, content=学习一下。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3c5555302, createdName=ms2000001082758263, createdTime=Wed Oct 20 18:32:57 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013244, encodeId=5782101324489, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56812497153, createdName=张家小胖子爱学习, createdTime=Tue Aug 31 17:21:18 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971208, encodeId=4ac19e1208f2, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sat Jun 05 23:10:59 CST 2021, time=2021-06-05, status=1, ipAttribution=)]
2021-06-05 120c570cm03暂无昵称

谢谢

95 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科指南

静脉注射用免疫球蛋白在儿童血液/肿瘤性疾病中应用的儿科专家共识

拓展阅读

科室

工具

服务